Literature DB >> 18985542

Altered small-bowel mucosal vascular network in untreated coeliac disease.

Essi Myrsky1, Mari Syrjänen, Ilma R Korponay-Szabo, Markku Mäki, Katri Kaukinen, Katri Lindfors.   

Abstract

OBJECTIVE: It has recently been shown that serum autoantibodies targeted against transglutaminase 2 derived from untreated coeliac patients can disturb several steps of angiogenesis in vitro. The purpose of this study was to establish whether the small-bowel mucosal vasculature is altered in coeliac disease and whether the putative changes are gluten dependent.
MATERIAL AND METHODS: The small-bowel mucosal microvessel architecture was examined in duodenal biopsy samples from coeliac patients before and after a gluten-free diet and from non-coeliac controls. In addition, the vasculature was subjected to a detailed morphometric analysis. Double immunofluorescent stainings of the vasculature with anti- alpha-smooth muscle actin antibody were performed in order to assess the maturity of mucosal vessels. Coeliac disease-specific transglutaminase 2-targeted autoantibody deposits in the vessel wall were studied using triple immunofluorescent stainings.
RESULTS: On a gluten-containing diet the mucosal vasculature in the small intestine of untreated coeliac disease patients was altered in overall organization as well as in the number and maturity of the vessels when compared to healthy subjects. In patients on a gluten-free diet, the vasculature normalized parallel to mucosal recovery.
CONCLUSIONS: In coeliac disease, ingestion of gluten leads to altered appearance of small-bowel mucosal microvasculature. It is thus conceivable that the small-bowel mucosal vascular biology might be involved in the pathogenesis of coeliac disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18985542     DOI: 10.1080/00365520802400875

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  15 in total

1.  Celiac disease patient IgA antibodies induce endothelial adhesion and cell polarization defects via extracellular transglutaminase 2.

Authors:  Cristina Antonella Nadalutti; Ilma Rita Korponay-Szabo; Katri Kaukinen; Martin Griffin; Markku Mäki; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2013-08-28       Impact factor: 9.261

Review 2.  Antibodies in celiac disease: implications beyond diagnostics.

Authors:  Sergio Caja; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 3.  Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.

Authors:  Stefania Martucciello; Gaetana Paolella; Carla Esposito; Marilena Lepretti; Ivana Caputo
Journal:  Cell Mol Life Sci       Date:  2018-08-22       Impact factor: 9.261

4.  Frequency of Celiac Disease in Children with Peptic Ulcers.

Authors:  Gokhan Tumgor; Mehmet Agin; Figen Doran; Salih Cetiner
Journal:  Dig Dis Sci       Date:  2018-06-26       Impact factor: 3.199

5.  RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies.

Authors:  Stefania Martucciello; Miha Lavric; Boglarka Toth; Toth Boglarka; Ilma Korponay-Szabo; Cristina Nadalutti; Essi Myrsky; Tiina Rauhavirta; Carla Esposito; Ana-Marija Sulic; Daniele Sblattero; Roberto Marzari; Markku Mäki; Katri Kaukinen; Katri Lindfors; Sergio Caja
Journal:  J Mol Med (Berl)       Date:  2012-01-06       Impact factor: 4.599

6.  Anti-microbial antibodies in celiac disease: trick or treat?

Authors:  Maria Papp; Ildiko Foldi; Istvan Altorjay; Eszter Palyu; Miklos Udvardy; Judit Tumpek; Sandor Sipka; Ilma Rita Korponay-Szabo; Eva Nemes; Gabor Veres; Tamas Dinya; Attila Tordai; Hajnalka Andrikovics; Gary L Norman; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

7.  Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.

Authors:  Essi Myrsky; Sergio Caja; Zsofi Simon-Vecsei; Ilma R Korponay-Szabo; Cristina Nadalutti; Russell Collighan; Alexandre Mongeot; Martin Griffin; Markku Mäki; Katri Kaukinen; Katri Lindfors
Journal:  Cell Mol Life Sci       Date:  2009-08-13       Impact factor: 9.261

8.  Celiac Disease-Specific TG2-Targeted Autoantibodies Inhibit Angiogenesis Ex Vivo and In Vivo in Mice by Interfering with Endothelial Cell Dynamics.

Authors:  Suvi Kalliokoski; Ana-Marija Sulic; Ilma R Korponay-Szabó; Zsuzsa Szondy; Rafael Frias; Mileidys Alea Perez; Stefania Martucciello; Anne Roivainen; Lauri J Pelliniemi; Carla Esposito; Martin Griffin; Daniele Sblattero; Markku Mäki; Katri Kaukinen; Katri Lindfors; Sergio Caja
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

9.  Celiac anti-type 2 transglutaminase antibodies induce phosphoproteome modification in intestinal epithelial Caco-2 cells.

Authors:  Gaetana Paolella; Ivana Caputo; Anna Marabotti; Marilena Lepretti; Anna Maria Salzano; Andrea Scaloni; Monica Vitale; Nicola Zambrano; Daniele Sblattero; Carla Esposito
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

10.  MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis.

Authors:  Hesen Peng; Junjie Ma; Yun Bai; Jianwei Lu; Tianwei Yu
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.